Supreme Court Lets Merck Loss In Fosamax Case Stand
The decision lets stand a ruling by the U.S. Court of Appeals for the Federal Circuit that the patent on the once-weekly osteoporosis drug Fosamax will expire in February 2008, a decade earlier than expected.
The court denied Merck's appeal without comment. Chief Justice John Roberts and Justices Sandra Day O'Connor and Stephen Breyer had...
To view the full article, register now.